Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study

Maxim Grymonprez, Tine L. De Backer, Xander Bertels, Stephane Steurbaut, Lies Lahousse*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)
156 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science